Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03636477
Title A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ziopharm
Indications

glioblastoma

Therapies

Ad-RTS-IL-12 plus AL + Nivolumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.